Suppression of Cancer Cell Growth by Promoting Cyclin D1 Degradation

Molecular Cell

Volumn 36, Issue 3, 2009, Pages 469-476

  Shan, Jing ^a   Zhao, Wenhui ^a   Gu, Wei ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

CELLCYCLE; HUMDISEASE

Indexed keywords

CYCLIN D1;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL GROWTH; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING;

BLOTTING, WESTERN; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; ENDOPEPTIDASES; FLOW CYTOMETRY; HCT116 CELLS; HUMANS; NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN; UBIQUITINATION;

EID: 70449105984     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2009.10.018     Document Type: Article

References (33)

1. Barbash O., and Diehl J.A. SCF(Fbx4/alphaB-crystallin) E3 ligase: when one is not enough. Cell Cycle 7 (2008) 2983-2986
2. Barbash O., Zamfirova P., Lin D.I., Chen X., Yang K., Nakagawa H., Lu F., Rustgi A.K., and Diehl J.A. Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer. Cancer Cell 14 (2008) 68-78
3. Brooks C.L., and Gu W. p53 ubiquitination: Mdm2 and beyond. Mol. Cell 21 (2006) 307-315
4. Brummelkamp T.R., Nijman S.M., Dirac A.M., and Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424 (2003) 797-801
5. Cheon K.W., and Baek K.H. HAUSP as a therapeutic target for hematopoietic tumors. Int. J. Oncol. 28 (2006) 1209-1215
6. Cohn M.A., Kowal P., Yang K., Haas W., Huang T.T., Gygi S.P., and D'Andrea A.D. A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. Mol. Cell 28 (2007) 786-797
7. Cummins J.M., and Vogelstein B. HAUSP is required for p53 destabilization. Cell Cycle 3 (2004) 689-692
8. D'Andrea A., and Pellman D. Deubiquitinating enzymes: a new class of biological regulators. Crit. Rev. Biochem. Mol. Biol. 33 (1998) 337-352
9. Diehl J.A. Cycling to cancer with cyclin D1. Cancer Biol. Ther. 1 (2002) 226-231
10. Ewen M.E., Sluss H.K., Sherr C.J., Matsushime H., Kato J., and Livingston D.M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73 (1993) 487-497
11. Fantl V., Stamp G., Andrews A., Rosewell I., and Dickson C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9 (1995) 2364-2372
12. Graner E., Tang D., Rossi S., Baron A., Migita T., Weinstein L.J., Lechpammer M., Huesken D., Zimmermann J., Signoretti S., et al. The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell 5 (2004) 253-261
13. Hu M., Li P., Li M., Li W., Yao T., Wu J.W., Gu W., Cohen R.E., and Shi Y. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 111 (2002) 1041-1054
14. Landis M.W., Pawlyk B.S., Li T., Sicinski P., and Hinds P.W. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. Cancer Cell 9 (2006) 13-22
15. Lee Y.M., and Sicinski P. Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human. Cell Cycle 5 (2006) 2110-2114
16. Li M., Chen D., Shiloh A., Luo J., Nikolaev A.Y., Qin J., and Gu W. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416 (2002) 648-653
17. Li M., Brooks C.L., Kon N., and Gu W. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 13 (2004) 879-886
18. Li Z., Wang C., Prendergast G.C., and Pestell R.G. Cyclin D1 functions in cell migration. Cell Cycle 5 (2006) 2440-2442
19. Lin D.I., Barbash O., Kumar K.G., Weber J.D., Harper J.W., Klein-Szanto A.J., Rustgi A., Fuchs S.Y., and Diehl J.A. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. Mol. Cell 24 (2006) 355-366
20. Luo J., Solimini N.L., and Elledge S.J. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136 (2009) 823-837
21. Meulmeester E., Maurice M.M., Boutell C., Teunisse A.F., Ovaa H., Abraham T.E., Dirks R.W., and Jochemsen A.G. Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2. Mol. Cell 18 (2005) 565-576
22. Nijman S.M., Luna-Vargas M.P., Velds A., Brummelkamp T.R., Dirac A.M., Sixma T.K., and Bernards R. A genomic and functional inventory of deubiquitinating enzymes. Cell 123 (2005) 773-786
23. Nijman S.M., Huang T.T., Dirac A.M., Brummelkamp T.R., Kerkhoven R.M., D'Andrea A.D., and Bernards R. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell 17 (2005) 331-339
24. Okabe H., Lee S.H., Phuchareon J., Albertson D.G., McCormick F., and Tetsu O. A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. PLoS ONE 1 (2006) e128
25. Popov N., Wanzel M., Madiredjo M., Zhang D., Beijersbergen R., Bernards R., Moll R., Elledge S.J., and Eilers M. The ubiquitin-specific protease USP28 is required for MYC stability. Nat. Cell Biol. 9 (2007) 765-774
26. Priolo C., Tang D., Brahamandan M., Benassi B., Sicinska E., Ogino S., Farsetti A., Porrello A., Finn S., Zimmermann J., et al. The isopeptidase USP2a protects human prostate cancer from apoptosis. Cancer Res. 66 (2006) 8625-8632
27. Schoenfeld A.R., Apgar S., Dolios G., Wang R., and Aaronson S.A. BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage. Mol. Cell. Biol. 24 (2004) 7444-7455
28. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
29. Sicinski P., Donaher J.L., Parker S.B., Li T., Fazeli A., Gardner H., Haslam S.Z., Bronson R.T., Elledge S.J., and Weinberg R.A. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82 (1995) 621-630
30. Stevenson L.F., Sparks A., Allende-Vega N., Xirodimas D.P., Lane D.P., and Saville M.K. The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2. EMBO J. 26 (2007) 976-986
31. Ventii K.H., and Wilkinson K.D. Protein partners of deubiquitinating enzymes. Biochem. J. 414 (2008) 161-175
32. Weinstein I.B. Cancer. Addiction to oncogenes-the Achilles heal of cancer. Science 297 (2002) 63-64
33. Wertz I.E., O'Rourke K.M., Zhou H., Eby M., Aravind L., Seshagiri S., Wu P., Wiesmann C., Baker R., Boone D.L., et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signaling. Nature 430 (2004) 694-699